1. Home
  2. TCMD vs CRMD Comparison

TCMD vs CRMD Comparison

Compare TCMD & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tactile Systems Technology Inc.

TCMD

Tactile Systems Technology Inc.

N/A

Current Price

$25.63

Market Cap

541.6M

Sector

Health Care

ML Signal

N/A

Logo CorMedix Inc.

CRMD

CorMedix Inc.

N/A

Current Price

$5.29

Market Cap

590.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TCMD
CRMD
Founded
1995
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.6M
590.7M
IPO Year
2016
2009

Fundamental Metrics

Financial Performance
Metric
TCMD
CRMD
Price
$25.63
$5.29
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
★ $36.33
$13.80
AVG Volume (30 Days)
186.9K
★ 2.1M
Earning Date
11-02-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
17.14
★ 780.00
EPS
0.57
0.57
Revenue
N/A
★ $311,709,000.00
Revenue This Year
$9.95
$8.05
Revenue Next Year
$9.49
N/A
P/E Ratio
$45.61
★ $8.89
Revenue Growth
N/A
★ 617.03
52 Week Low
$20.53
$4.47
52 Week High
$37.77
$13.02

Technical Indicators

Market Signals
Indicator
TCMD
CRMD
Relative Strength Index (RSI) 53.31 39.61
Support Level $23.14 N/A
Resistance Level $27.06 $8.97
Average True Range (ATR) 1.33 0.38
MACD -0.10 0.00
Stochastic Oscillator 59.65 58.87

Price Performance

Historical Comparison
TCMD
CRMD

About TCMD Tactile Systems Technology Inc.

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: